Vital Signs

This issue of Vital Signs, released on January 28, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

This issue of Vital Signs, released on December 31, 2012, provides Frost & Sullivan's perspectives on the NYeC Digital Health Conference in New York during Q4 2012, including top takeaways from this event, as well as an overview of the conference, summary of an interview with NYeC, and a listing of companies comprising the inaugural class of the Ne...

This issue of Vital Signs, released on November 23, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

This issue of Vital Signs, released on November 23, 2012, provides an insight in to breast screening against the backdrop of the recent changes in breast density reporting laws in the United States. Additionally, a company spotlight is provided for MinXray. Founded in 1967, MinXray, Inc. is a worldwide provider of transportable x-ray imaging eq...

This issue of Vital Signs, released on November 14, 2012, provides in-depth commentary on the 26th annual scientific meeting of the Association for Vascular Access (AVA) held October 16-19 in San Antonio, Texas.

This issue of Vital Signs, released on October 22, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

This issue of Vital Signs, released on October 8, 2012, provides a strategic insight on the use of healthcare information technology in combatting hospital-acquired infections. Additionally, a company spotlight is provided for Hospira. Hospira, Inc.(NYSE: HSP) is a large global supplier of injectable drugs and infusion technologies for hospital...

This issue of Vital Signs, released on September 28, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

This issue of Vital Signs, released on September 26, 2012, provides an insight in to the research antibodies market place. The survey captures the purchasing, budget, application, and technology trends of research antibody use. Additionally, the survey determines customer ratings of suppliers, supplier usage, unmet needs, and challenges.